Callio Therapeutics Aims To Overcome Enhertu Resistance With Multi-Payload ADCs

Singapore (Prasit Rodphan/Shutterstock.com)
Callio Therapeutics is based in Singapore and Seattle. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Start-Ups & SMEs

More from Financing